Korean J Neuromuscul Disord.
2021 Dec;13(2):52-54. 10.46518/kjnmd.2021.13.2.52.
Amphiphilic Myopathy Induced by Hydroxychloroquine Presenting with Dysarthria
- Affiliations
-
- 1Department of Neurology, Hanyang University College of Medicine, Seoul, Korea
- KMID: 2523955
- DOI: http://doi.org/10.46518/kjnmd.2021.13.2.52
Abstract
- Chloroquine and hydroxychloroquine (HCQ) are commonly used antimalarial agents as the treatment for a wide range of autoimmune disorders including dermatological, rheumatoid, and connective tissue diseases. These amphiphilic drugs can cause toxic myopathy in in patients which are commonly characterized as reversible proximal muscle weakness, dysphagia and dyspnea. Herein, we report a case of a patient on HCQ, who suffered from toxic myopathy presenting as proximal muscle weakness and dysarthria, which was fully recovered after the cessation.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Hydroxychloroquine-Induced Cutaneous Hyperpigmentation
- Successful Treatment of Hydroxychloroquine-Induced Recalcitrant Acute Generalized Exanthematous Pustulosis with Cyclosporine: Case Report and Literature Review
- A Case of Rhabdomyolysis in a Patient with Plasmidium vivax Malaria Treated with Hydroxychloroquine
- Statin-Induced Autoimmune Necrotizing Myopathy Responsive to Immunosuppressive Therapy
- Skull Base Tumor Presenting as Dysarthria and Tongue Deviation
